These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9562141)

  • 21. Testosterone replacement, weight lifting help wasting.
    AIDS Alert; 1996 Jun; 11(6):suppl 1-2. PubMed ID: 11363546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The etiology of wasting in the human immunodeficiency virus and acquired immunodeficiency syndrome.
    Strawford A; Hellerstein M
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):76-81. PubMed ID: 9625388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment guidelines for HIV-associated wasting.
    Nemechek PM; Polsky B; Gottlieb MS
    Mayo Clin Proc; 2000 Apr; 75(4):386-94. PubMed ID: 10761494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combating malnutrition in HIV infection.
    Berger DS
    AIDS Patient Care STDS; 1996 Apr; 10(2):94-100. PubMed ID: 11361713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The HIV wasting syndrome: a review.
    Coodley GO; Loveless MO; Merrill TM
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):681-94. PubMed ID: 8207646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting.
    Grinspoon S; Corcoran C; Miller K; Biller BM; Askari H; Wang E; Hubbard J; Anderson EJ; Basgoz N; Heller HM; Klibanski A
    J Clin Endocrinol Metab; 1997 May; 82(5):1332-7. PubMed ID: 9141512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anorexia/cachexia in patients with HIV: lessons for the oncologist.
    Von Roenn JH; Knopf K
    Oncology (Williston Park); 1996 Jul; 10(7):1049-56; discussion 1062-4, 1067-8. PubMed ID: 8837121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing megestrol acetate therapy with oxandrolone therapy for HIV-related weight loss: similar results in 2 months.
    Mwamburi DM; Gerrior J; Wilson IB; Chang H; Scully E; Saboori S; Miller L; Forfia J; Albrecht M; Wanke CA
    Clin Infect Dis; 2004 Mar; 38(6):895-902. PubMed ID: 14999637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of growth hormone and other anabolic agents in AIDS wasting.
    Mulligan K; Tai VW; Schambelan M
    JPEN J Parenter Enteral Nutr; 1999; 23(6 Suppl):S202-9. PubMed ID: 10571456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NIH conference on AIDS wasting syndrome. National Institutes of Health.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Aug; 3(8):42-6. PubMed ID: 11364632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
    Mulligan K; Zackin R; Von Roenn JH; Chesney MA; Egorin MJ; Sattler FR; Benson CA; Liu T; Umbleja T; Shriver S; Auchus RJ; Schambelan M;
    J Clin Endocrinol Metab; 2007 Feb; 92(2):563-70. PubMed ID: 17090640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.
    Storer TW; Woodhouse LJ; Sattler F; Singh AB; Schroeder ET; Beck K; Padero M; Mac P; Yarasheski KE; Geurts P; Willemsen A; Harms MK; Bhasin S
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4474-82. PubMed ID: 15914526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Counteracting muscle wasting in HIV-infected individuals.
    Dudgeon WD; Phillips KD; Carson JA; Brewer RB; Durstine JL; Hand GA
    HIV Med; 2006 Jul; 7(5):299-310. PubMed ID: 16945075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The quality factor.
    HIV Hotline; 1998 May; 8(2):1-6. PubMed ID: 11365361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-associated wasting: brief review and discussion of the impact of oxandrolone.
    Taiwo BO
    AIDS Patient Care STDS; 2000 Aug; 14(8):421-5. PubMed ID: 10977971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxymetholone for the treatment of HIV-wasting: a double-blind, randomized, placebo-controlled phase III trial in eugonadal men and women.
    Hengge UR; Stocks K; Faulkner S; Wiehler H; Lorenz C; Jentzen W; Hengge D; Ringham G
    HIV Clin Trials; 2003; 4(3):150-63. PubMed ID: 12815555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant Mammalian Cell-Derived Somatropin: A Review of its Pharmacological Properties and Therapeutic Potential in the Management of Wasting Associated with HIV Infection.
    Perry CM; Wagstaff AJ
    BioDrugs; 1997 Nov; 8(5):394-414. PubMed ID: 18020529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nutritional alterations associated with HIV infection.
    Kotler DP
    J Acquir Immune Defic Syndr; 2000 Oct; 25 Suppl 1():S81-7. PubMed ID: 11126432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Energy expenditure and wasting in human immunodeficiency virus infection.
    Macallan DC; Noble C; Baldwin C; Jebb SA; Prentice AM; Coward WA; Sawyer MB; McManus TJ; Griffin GE
    N Engl J Med; 1995 Jul; 333(2):83-8. PubMed ID: 7777033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of unintentional weight loss in patients with cancer.
    Mattox TW
    Nutr Clin Pract; 2005 Aug; 20(4):400-10. PubMed ID: 16207680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.